1. Home
  2. EXEL vs PRMB Comparison

EXEL vs PRMB Comparison

Compare EXEL & PRMB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • EXEL
  • PRMB
  • Stock Information
  • Founded
  • EXEL 1994
  • PRMB 1955
  • Country
  • EXEL United States
  • PRMB United States
  • Employees
  • EXEL N/A
  • PRMB N/A
  • Industry
  • EXEL Biotechnology: Biological Products (No Diagnostic Substances)
  • PRMB
  • Sector
  • EXEL Health Care
  • PRMB
  • Exchange
  • EXEL Nasdaq
  • PRMB Nasdaq
  • Market Cap
  • EXEL 10.0B
  • PRMB 11.0B
  • IPO Year
  • EXEL 2000
  • PRMB N/A
  • Fundamental
  • Price
  • EXEL $34.59
  • PRMB $30.93
  • Analyst Decision
  • EXEL Buy
  • PRMB
  • Analyst Count
  • EXEL 17
  • PRMB 0
  • Target Price
  • EXEL $32.18
  • PRMB N/A
  • AVG Volume (30 Days)
  • EXEL 1.7M
  • PRMB 2.1M
  • Earning Date
  • EXEL 02-04-2025
  • PRMB 01-01-0001
  • Dividend Yield
  • EXEL N/A
  • PRMB 3.80%
  • EPS Growth
  • EXEL 441.02
  • PRMB N/A
  • EPS
  • EXEL 1.55
  • PRMB 140.65
  • Revenue
  • EXEL $2,081,598,000.00
  • PRMB $4,841,300,000.00
  • Revenue This Year
  • EXEL $20.59
  • PRMB N/A
  • Revenue Next Year
  • EXEL $1.50
  • PRMB N/A
  • P/E Ratio
  • EXEL $22.41
  • PRMB $0.22
  • Revenue Growth
  • EXEL 17.31
  • PRMB 9.01
  • 52 Week Low
  • EXEL $19.20
  • PRMB $14.06
  • 52 Week High
  • EXEL $36.97
  • PRMB $32.25
  • Technical
  • Relative Strength Index (RSI)
  • EXEL 51.61
  • PRMB N/A
  • Support Level
  • EXEL $34.30
  • PRMB N/A
  • Resistance Level
  • EXEL $36.22
  • PRMB N/A
  • Average True Range (ATR)
  • EXEL 0.75
  • PRMB 0.00
  • MACD
  • EXEL -0.29
  • PRMB 0.00
  • Stochastic Oscillator
  • EXEL 25.09
  • PRMB 0.00

About EXEL Exelixis Inc.

Exelixis is a biopharmaceutical firm that discovers, develops, and commercializes treatments for cancer. Its lead molecule, cabozantinib, is indicated for the treatment of patients with metastatic medullary thyroid cancer under the name Cometriq and for the treatment of kidney and liver cancer under the name Cabometyx. Exelixis and its partner Roche have also brought Cotellic to market for the treatment of melanoma.

About PRMB Primo Brands Corporation Class A Common Stock

Primo Brands Corp is a North American branded beverage company focused on healthy hydration. It delivers sustainably and domestically sourced diversified offerings across products, formats, channels, price points, and consumer occasions, distributed in every state and Canada. Primo Brands is in reusable packaging, helping to reduce waste through its reusable, multi-serve bottles and innovative brand packaging portfolio, which includes recycled plastic, aluminum, and glass.

Share on Social Networks: